Injectable self-crosslinking hydrogels based on hyaluronic acid as vitreous substitutes

Int J Biol Macromol. 2022 May 31:208:159-171. doi: 10.1016/j.ijbiomac.2022.03.046. Epub 2022 Mar 14.

Abstract

After vitrectomy, the ideal vitreous substitute should be implanted to maintain the normal function of the eye. However, the existing materials (such as silicone oil, air, perfluorocarbons, etc.) still have some shortcomings and cannot fully meet the clinical needs. In this study, thiolated hyaluronic acid (SH-HA) was prepared based on hyaluronic acid. The SH-HA hydrogel was formed by a simple transformation of the sulfhydryl group to the disulfide bond, which had high transparency, controllable swelling property, suitable mechanical strength, excellent biocompatibility and similar physical and chemical properties to natural vitreous. SH-HA hydrogel was filled into the eyes of experimental rabbits to replace their own vitreous after vitrectomy. During the 90 days follow-up period, SH-HA hydrogel showed excellent intraocular compatibility, maintained normal intraocular pressure (IOP), and no cataract, endophthalmitis, retinal detachment and other complications were observed. In general, SH-HA hydrogel has great potential as a vitreous substitute.

Keywords: Hyaluronic acid; Hydrogel; Vitreous substitute.

MeSH terms

  • Animals
  • Biocompatible Materials / chemistry
  • Endophthalmitis*
  • Hyaluronic Acid / chemistry
  • Hydrogels* / chemistry
  • Rabbits
  • Vitreous Body / surgery

Substances

  • Biocompatible Materials
  • Hydrogels
  • Hyaluronic Acid